Transcode Therapeutics, Inc.
For the period ended Jan 6, 2026. Filed Jan 6, 2026.
View on SEC.govAbout this filing
A notice of a major event between regular reports, such as results, a deal or a change of executives. It is often the first formal record of the news.
Jan 6, 2026 · Filed Jan 6, 2026
Use the contents to explore the available documents and sections.
RNAZ$1.49-1.3%Stored close · as of Nov 6, 2026
Contents
TransCode Therapeutics, Inc
6 Liberty Square**,#2382**
Boston**, Massachusetts **02109
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.